Agendia: The New Era of Genomic Testing in Early Stage Breast Cancer.
1:03:31
CAP TODAY - Show Me the Data! Multidisciplinary Treatment Planning in Early-Stage Breast Cancer
1:03:17
When to Consider Multi-Gene Testing in Early-Stage and Metastatic Breast Cancer
1:24:19
DGS 2023 – MammaPrint & BluePrint: Jung=Chemo und Endocrine4ever – Ist das wirklich richtig?
6:18
Who We Are - Agendia's Purpose, Story and Vision
59:18
Matchmaking Event: Erasmus+ Calls for Digital LSP Members
27:40
Prof.dr. Naomi Ellemers, Social Psychology of the Organization, Leiden University - Symposium Women
41:58
Molecular Profiling Diagnostics for Breast Cancer
24:02